COMPASS Pathways: the biotech aiming to beat depression with magic mushrooms
Psilocybin mushroom, aka "magic mushroom"
Share tips

COMPASS Pathways: the biotech aiming to beat depression with magic mushrooms

Biotech company COMPASS Pathways has produced a drug to treat depression based on the psychedelic substance found in magic mushrooms. Bruce Packard as…
8 Sep 2022
Why this biotech company has years of growth ahead
Surgeons
Biotech stocks

Why this biotech company has years of growth ahead

Zimmer Biomet, a leader in the worldwide market for hip and knee joints, enjoys a competitive advantage and has years of growth ahead, says Dr Mike Tu…
6 Sep 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Zantac
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022
A fund to provide a reliable income from biotech
Scientists doing science
Investment trusts

A fund to provide a reliable income from biotech

The BioPharma Credit investment trust lends to promising small drug developers.
18 Jul 2022
Investing in drugmakers: uncommon profits from curing rare diseases
MoneyWeek cover illustration
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
The mistakes pharmaceutical companies made with their Covid vaccines
Biotech stocks

The mistakes pharmaceutical companies made with their Covid vaccines

Covid-19 looked as if it would mark the start of a golden age for the pharmaceutical industry. It’s not worked out that way, says Matthew Lynn.
19 Mar 2022
Veterinary medicine stocks: the firms keeping your pet healthy
Share tips

Veterinary medicine stocks: the firms keeping your pet healthy

Pet ownership has grown due to the pandemic. That’s good news for animal health stocks, says Dr Mike Tubbs
11 Mar 2022
Cover of MoneyWeek magazine issue no 1022, Friday 23 October 2020

Subscribe to MoneyWeek and get your first six issues FREE

Subscribe to MoneyWeek now and get your first six magazine issues absolutely FREE
How Covid-19 changed biotechnology – and how you can invest
Biotech stocks

How Covid-19 changed biotechnology – and how you can invest

The pandemic has exacted a huge human and financial toll, but it has also transformed scientific research in ways that will deliver huge benefits for …
4 Mar 2022
Unilever slides and GSK bounces after GSK knocks back £50bn bid
UK stockmarkets

Unilever slides and GSK bounces after GSK knocks back £50bn bid

Unilever shares fell to their lowest level in around five years, after its £50bn takeover bid for GSK’s consumer health unit was rejected.
17 Jan 2022
The best vaccine-makers’ stocks to buy now
Biotech stocks

The best vaccine-makers’ stocks to buy now

The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an…
13 Jan 2022
Three biotech stocks to buy now
Share tips

Three biotech stocks to buy now

Professional investors Ailsa Craig and Marek Poszepczynski of the International Biotechnology Trust pick three of their favourite biotech stocks to bu…
10 Jan 2022
Get healthy returns from these three innovative healthcare stocks
Share tips

Get healthy returns from these three innovative healthcare stocks

Professional investor Michael Li of the American Century Advanced Medical Impact Fund looks at three healthcare stocks
28 Dec 2021
Stéphane Bancel: Moderna’s biotech whizz who changed the world
People

Stéphane Bancel: Moderna’s biotech whizz who changed the world

Stéphane Bancel had a safe job as CEO of a French multinational when he decided to risk it all on a promising but unproven medical technology. The bet…
12 Dec 2021
The huge potential of mRNA technology
Biotech stocks

The huge potential of mRNA technology

The new technology made its name when it delivered Covid-19 vaccines in record time. But it could be pressed into use in many other areas too. Simon W…
28 Oct 2021
Get healthy returns from these three healthcare stocks
Share tips

Get healthy returns from these three healthcare stocks

Professional investor Paul Major of the BB Healthcare Trust highlights three of his favourite healthcare stocks.
25 Oct 2021
University spin-outs: where to find companies involved in cutting-edge science
Share tips

University spin-outs: where to find companies involved in cutting-edge science

Universities are innovation incubators and often launch businesses involved in fast-growing fields ranging from biotechnology to artificial intelligen…
24 Sep 2021
AstraZeneca’s Covid troubles could see it pull out of making vaccines
Biotech stocks

AstraZeneca’s Covid troubles could see it pull out of making vaccines

AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
6 Aug 2021
A great leap forward in the war against Alzheimer’s disease
Biotech stocks

A great leap forward in the war against Alzheimer’s disease

The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs.…
16 Jul 2021
Shake-up at GSK won’t placate investors
UK stockmarkets

Shake-up at GSK won’t placate investors

GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance…
2 Jul 2021
Two investment trusts that have proved their worth
Investment trusts

Two investment trusts that have proved their worth

These two investment trusts have earned investors’ confidence since their flotations and remain solid bets, says Max King.
25 Jun 2021
Mid Wynd International investment trust update: premium to net asset value falls
Investment trusts

Mid Wynd International investment trust update: premium to net asset value falls

The Mid Wynd International investment trust saw a big fall in its premium relative to its net asset value in May, with a fall in the share price, too.…
23 Jun 2021
Investing in stem cells, the building blocks of the body
Share tips

Investing in stem cells, the building blocks of the body

Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disea…
18 Jun 2021